Cytokinetics Inc

CYTK

Equity

ISIN null / Valor 21533074

NASDAQ (2026-10-02)

USD 65.60-0.03%

Cytokinetics Inc
UMushroom community rating:

4.33 3 votes No rating yet

NegativeNeutralPositive

About company

Cytokinetics Inc. is a biopharmaceutical company with a specialized focus on the development of innovative therapies aimed at enhancing muscle function for individuals suffering from debilitating diseases where muscle performance is compromised. Established over 25 years ago in South San Francisco, California, the company has carved a niche in muscle biology, pioneering the discovery, development, and commercialization of muscle activators and inhibitors. These novel therapeutic agents are designed as potential treatments for a range of serious conditions affecting muscle health. Under the leadership of experienced industry professionals, Cytokinetics has made significant strides in scientific research, evidenced by its extensive portfolio of over 115 scientific publications, participation in more than 100 clinical trials, and the securing of numerous patents. The company's commitment to advancing muscle biology research extends to its active engagement with the healthcare and scientific communities through peer-reviewed journals and medical forums, aiming to contribute meaningfully to patient care and medical knowledge.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

16.5%1Y

135%3Y

78.6%5Y

Performance

44.0%1Y

65.5%3Y

61.8%5Y

Volatility